Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (600332) — Cash Flow-to-Debt Ratio
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (600332) has a Cash Flow-to-Debt Ratio of 0.04x as of December 2025, meaning its operating cash flow of CN¥1.84 Billion could theoretically repay 0% of its total liabilities (CN¥43.39 Billion) in one year. See Guangzhou Baiyunshan Pharmaceutical Hold free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Cash Flow-to-Debt Ratio (2000–2025)
Historical debt coverage capacity for Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd across 26 annual periods. Also explore net asset momentum of Guangzhou Baiyunshan Pharmaceutical Hold to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (2000–2025)
Year-by-year debt coverage analysis for Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd. For market capitalisation and broader financial context, see 600332 company net worth.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.01x | CN¥260.23 Million | CN¥43.39 Billion | ▼ -92.3% |
| 2024 | 0.08x | CN¥3.44 Billion | CN¥43.91 Billion | ▼ -19.9% |
| 2023 | 0.10x | CN¥4.10 Billion | CN¥41.91 Billion | ▼ -42.6% |
| 2022 | 0.17x | CN¥7.00 Billion | CN¥41.03 Billion | ▲ +4.6% |
| 2021 | 0.16x | CN¥5.67 Billion | CN¥34.79 Billion | ▲ +779.3% |
| 2020 | 0.02x | CN¥585.19 Million | CN¥31.55 Billion | ▼ -88.6% |
| 2019 | 0.16x | CN¥5.02 Billion | CN¥30.90 Billion | ▼ -11.7% |
| 2018 | 0.18x | CN¥5.22 Billion | CN¥28.34 Billion | ▼ -9.1% |
| 2017 | 0.20x | CN¥1.83 Billion | CN¥9.05 Billion | ▼ -31.7% |
| 2016 | 0.30x | CN¥2.44 Billion | CN¥8.24 Billion | ▲ +9.7% |
| 2015 | 0.27x | CN¥1.94 Billion | CN¥7.19 Billion | ▼ -4.1% |
| 2014 | 0.28x | CN¥1.76 Billion | CN¥6.25 Billion | ▲ +10.0% |
| 2013 | 0.26x | CN¥1.34 Billion | CN¥5.23 Billion | ▲ +1.7% |
| 2012 | 0.25x | CN¥506.53 Million | CN¥2.01 Billion | ▲ +233.7% |
| 2011 | -0.19x | CN¥-180.05 Million | CN¥956.09 Million | ▼ -314.9% |
| 2010 | 0.09x | CN¥73.17 Million | CN¥835.05 Million | ▼ -83.6% |
| 2009 | 0.54x | CN¥439.39 Million | CN¥820.92 Million | ▲ +7845.1% |
| 2008 | 0.01x | CN¥6.10 Million | CN¥905.99 Million | ▼ -94.8% |
| 2007 | 0.13x | CN¥375.74 Million | CN¥2.91 Billion | ▲ +714.6% |
| 2006 | 0.02x | CN¥38.88 Million | CN¥2.46 Billion | ▼ -75.2% |
| 2005 | 0.06x | CN¥146.32 Million | CN¥2.29 Billion | ▼ -18.9% |
| 2004 | 0.08x | CN¥200.54 Million | CN¥2.55 Billion | ▲ +2533.8% |
| 2003 | 0.00x | CN¥-6.83 Million | CN¥2.11 Billion | ▼ -103.4% |
| 2002 | 0.10x | CN¥169.01 Million | CN¥1.75 Billion | ▼ -2.6% |
| 2001 | 0.10x | CN¥140.15 Million | CN¥1.41 Billion | ▼ -45.9% |
| 2000 | 0.18x | CN¥286.95 Million | CN¥1.57 Billion | — |